275 related articles for article (PubMed ID: 20419303)
21. Percutaneous CT-Guided Radiofrequency Ablation of Solitary Small Renal Masses: A Single Center Experience.
Pieper CC; Fischer S; Strunk H; Meyer C; Thomas D; Willinek WA; Hauser S; Nadal J; Schild H; Wilhelm K
Rofo; 2015 Jul; 187(7):577-83. PubMed ID: 25962750
[TBL] [Abstract][Full Text] [Related]
22. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
Lyrdal D; Andersson M; Hellström M; Sternal J; Lundstam S
Acta Radiol; 2010 Sep; 51(7):808-18. PubMed ID: 20707665
[TBL] [Abstract][Full Text] [Related]
23. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
[TBL] [Abstract][Full Text] [Related]
24. Radiofrequency ablation of renal tumors in the solitary kidney.
Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
[TBL] [Abstract][Full Text] [Related]
25. Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease.
Wehrenberg-Klee E; Clark TW; Malkowicz SB; Soulen MC; Wein AJ; Mondschein JI; Van Arsdalen K; Guzzo TJ; Stavropoulos SW
J Vasc Interv Radiol; 2012 Jan; 23(1):41-5. PubMed ID: 22019179
[TBL] [Abstract][Full Text] [Related]
26. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
27. Laparoscopic renal cryoablation: acute and long-term clinical, radiographic, and pathologic effects in an animal model and application in a clinical trial.
Bishoff JT; Chen RB; Lee BR; Chan DY; Huso D; Rodriguez R; Kavoussi LR; Marshall FF
J Endourol; 1999 May; 13(4):233-9. PubMed ID: 10405898
[TBL] [Abstract][Full Text] [Related]
28. Central and deep renal tumors can be effectively ablated: radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring.
Wingo MS; Leveillee RJ
J Endourol; 2008 Jun; 22(6):1261-7. PubMed ID: 18484892
[TBL] [Abstract][Full Text] [Related]
29. Difference of opinion - Which is the best treatment on a 2 cm complete endophitic tumor on the posterior side of the left kidney? Opinion: Cryoablation.
Garcia RG
Int Braz J Urol; 2016; 42(1):3-7. PubMed ID: 27120776
[No Abstract] [Full Text] [Related]
30. RFA of renal cell carcinoma in a solitary kidney.
Hoffmann RT; Jakobs TF; Trumm C; Helmberger TK; Reiser MF
Abdom Imaging; 2008; 33(2):230-6. PubMed ID: 17401600
[TBL] [Abstract][Full Text] [Related]
31. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI.
Meloni MF; Bertolotto M; Alberzoni C; Lazzaroni S; Filice C; Livraghi T; Ferraioli G
AJR Am J Roentgenol; 2008 Oct; 191(4):1233-8. PubMed ID: 18806170
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous treatment of renal tumours.
Uppot RN; Wah TM; Mueller PR
J Med Imaging Radiat Oncol; 2023 Dec; 67(8):853-861. PubMed ID: 37417722
[TBL] [Abstract][Full Text] [Related]
33. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results.
Hoffmann RT; Jakobs TF; Kubisch CH; Trumm C; Weber C; Siebels M; Helmberger TK; Reiser MF
Eur J Radiol; 2010 Mar; 73(3):652-6. PubMed ID: 19181470
[TBL] [Abstract][Full Text] [Related]
34. Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results.
Karam JA; Ahrar K; Vikram R; Romero CA; Jonasch E; Tannir NM; Rao P; Wood CG; Matin SF
BJU Int; 2013 May; 111(6):997-1005. PubMed ID: 23510233
[TBL] [Abstract][Full Text] [Related]
35. Incidence of multiple sporadic renal cell carcinomas in patients referred for renal radiofrequency ablation: implications for imaging follow-up.
Beland MD; Wolf FJ; Grand DJ; Dupuy DE; Mayo-Smith WW
AJR Am J Roentgenol; 2011 Sep; 197(3):671-5. PubMed ID: 21862810
[TBL] [Abstract][Full Text] [Related]
36. Minimally invasive treatment of small renal tumors: trends in renal cancer diagnosis and management.
Breen DJ; Railton NJ
Cardiovasc Intervent Radiol; 2010 Oct; 33(5):896-908. PubMed ID: 20544228
[TBL] [Abstract][Full Text] [Related]
37. Early experience with percutaneous radiofrequency ablation of small solid renal masses.
Roy-Choudhury SH; Cast JE; Cooksey G; Puri S; Breen DJ
AJR Am J Roentgenol; 2003 Apr; 180(4):1055-61. PubMed ID: 12646454
[TBL] [Abstract][Full Text] [Related]
38. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
Gupta A; Raman JD; Leveillee RJ; Wingo MS; Zeltser IS; Lotan Y; Trimmer C; Stern JM; Cadeddu JA
J Endourol; 2009 Jul; 23(7):1099-105. PubMed ID: 19530948
[TBL] [Abstract][Full Text] [Related]
39. Contrast-Enhanced Subharmonic and Harmonic Ultrasound of Renal Masses Undergoing Percutaneous Cryoablation.
Eisenbrey JR; Shaw CM; Lyshchik A; Machado P; Lallas CD; Trabulsi EJ; Merton DA; Fox TB; Liu JB; Brown DB; Forsberg F
Acad Radiol; 2015 Jul; 22(7):820-6. PubMed ID: 25882093
[TBL] [Abstract][Full Text] [Related]
40. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
